Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective
Cancer Reports · 2025
DOI: 10.1002/cnr2.70300 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Chunming Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Gua…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antigens, Neoplasm, Biomarkers, Tumor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2018 Entrepreneurial Leading Talent of Guangzhou Huangpu District and Guangzhou Development District, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation of China.
Abstract (Originalsprache)
Background
Immunotherapies including immune checkpoint inhibitors and tumor antigen based vaccines have revolutionized cancer treatment. However, immune signatures of hepatocellular carcinoma (HCC) have not been thoroughly studied from a multiomics perspective.
Aims
In this study, we aimed to identify the potential tumor antigens and immune subtyping for HCC using multiomics data. Methods and Results The study included 159 HCC patients with genome, transcriptome, proteome, and phosphoproteome data. Two potential tumor antigens, ZNF831 and SYNE1, showed significant superior prognostic effects and positive correlations with antigen presenting cells, which provided promising candidates for the development of tumor antigen‐based mRNA vaccine. A multiomics clustering using the most variable tumor antigen genes of transcriptome, proteome, and phosphoproteome was performed, resulting in two HCC subtypes with distinct clinical and molecular features. In order to further explore the complex tumor microenvironment, we implemented an immune subtyping using 30 most important immune‐related features generated from the random forest algorithm. Four immune subtypes were constructed, which exhibited diverse molecular attributes including immune cell activities, angiogenesis, cell proliferation, and the expression of tumor antigen genes, immune checkpoints, and immunogenic cell death modulators.
Conclusion
In summary, we found two potential tumor antigens, ZNF831 and SYNE1, and identified four immune subtypes of HCC with distinct molecular features. Our study provides novel insights into the development of cancer vaccine and precision medicine of immune oncology in HCC, which may benefit clinical practice in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Live…
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Burning Rock Biotech, Guangzhou, China.
ORCID-Profile: Mingxin Pan
Förderung
- 2018 Entrepreneurial Leading Talent of Guangzhou Huangpu District and Guangzhou Development District
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation of China
Zitieren
APA
Wang, C., Cai, L., Xie, Q., Zhang, C., Chen, X., Cui, P., Wang, G., Cai, S., Han, Y., Zhong, K., He, G., Fu, S., Xu, Y., He, J., & Pan, M. (2025). Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective. Cancer Reports. https://doi.org/10.1002/cnr2.70300
Vancouver
Wang C, Cai L, Xie Q, Zhang C, Chen X, Cui P, et al. Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective. Cancer Reports. 2025. doi:10.1002/cnr2.70300
BibTeX
@article{Wang2025,
author = {Wang, Chunming and Cai, Lei and Xie, Qingyu and Zhang, Cheng and Chen, Xuefang and Cui, Peng and Wang, Guoqiang and Cai, Shangli and Han, Yusheng and Zhong, Kaihang and He, Guolin and Fu, Shunjun and Xu, Yuyan and He, Junming and Pan, Mingxin},
title = {Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70300}
}
EUVIMED